Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

A CCS patient with severe complications was successfully treated using combined therapies.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Mice with CBS deficiency are healthier on a low-methionine diet.

Traditional Chinese medicine may help relieve symptoms of Cronkhite-Canada syndrome.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Most children with MIS-C showed significant improvement by 6 months.

The method accurately measures hormones and endocannabinoids in mice, showing gut microbiota diversity affects these levels and may influence stress and reproductive systems.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Severe CCCA may be biologically and clinically different from milder forms.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Adult mice with CBS deficiency show minimal health issues and normal lifespan despite high homocysteine levels.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

There is no standard treatment for CCCA, and practices vary widely.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

A new one-step test can quickly identify skin cancer during surgery.

Multibranch carboxyl-modified cellulose is a safe and effective material for stopping bleeding.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Early diagnosis with trichoscopy can improve management and quality of life for CCCA patients.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

ASA and CM may protect the brain and work better together.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Early diagnosis and treatment with corticosteroids can improve outcomes in Cronkhite–Canada syndrome.